{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T13:20:02Z","timestamp":1769088002801,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["KAKENHI-18H02385"],"award-info":[{"award-number":["KAKENHI-18H02385"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009035","name":"Program on Open Innovation Platform with Enterprises, Research Institute and Academia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009035","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.vaccine.2025.127742","type":"journal-article","created":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:19:12Z","timestamp":1757765952000},"page":"127742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Trace amounts of cobalt serve as an adjuvant for unglycosylated JEV-ED3 expressed in E. coli, inducing a potent virus-neutralizing immune response"],"prefix":"10.1016","volume":"64","author":[{"given":"Md. Din","family":"Islam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kurosu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mami","family":"Okawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanaka","family":"Morikoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Monirul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromichi","family":"Tsurui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vaccine.2025.127742_bb0005","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0958-1669(95)80112-X","article-title":"Recombinant proteins for medical use: the attractions and challenges","volume":"6","author":"Koths","year":"1995","journal-title":"Curr Opin Biotechnol"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127742_bb0010","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/cmdc.201200487","article-title":"Modern subunit vaccines: development, components, and research opportunities","volume":"8","author":"Moyle","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.vaccine.2025.127742_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2014.00172","article-title":"Recombinant protein expression in Escherichia coli: advances and challenges","volume":"5","author":"Rosano","year":"2014","journal-title":"Front Microbiol"},{"issue":"14","key":"10.1016\/j.vaccine.2025.127742_bb0020","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/0264-410X(95)00011-O","article-title":"Adjuvants for human vaccines\u2014current status, problems and future prospects","volume":"13","author":"Gupta","year":"1995","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127742_bb0025","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0264-410X(93)90190-9","article-title":"Adjuvants \u2014 a balance between toxicity and adjuvanticity","volume":"11","author":"Gupta","year":"1993","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127742_bb0030","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine adjuvants: putting innate immunity to work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127742_bb0035","first-page":"1","article-title":"Vaccine adjuvants: mechanisms and platforms","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"4514","key":"10.1016\/j.vaccine.2025.127742_bb0040","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1126\/science.7022654","article-title":"The essential trace elements","volume":"213","author":"Mertz","year":"1981","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2025.127742_bb0045","series-title":"Trace metals and infectious diseases","article-title":"Impact of metals on immune response and tolerance, and modulation of metal metabolism during infection","author":"Weiss","year":"2015"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127742_bb0050","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.tim.2012.01.005","article-title":"Metallobiology of host\u2013pathogen interactions: an intoxicating new insight","volume":"20","author":"Botella","year":"2012","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2025.127742_bb0055","article-title":"Immunomodulatory activity of manganese dioxide nanoparticles: promising for novel vaccines and immunotherapeutics","volume":"14","author":"Huang","year":"2023","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127742_bb0060","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.2217\/nnm.12.35","article-title":"Adjuvanticity and toxicity of cobalt oxide nanoparticles as an alternative vaccine adjuvant","volume":"7","author":"Cho","year":"2012","journal-title":"Nanomedicines"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127742_bb0065","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.vaccine.2019.10.073","article-title":"Immunogenicity of the Lyme disease antigen OspA, particleized by cobalt porphyrin-phospholipid liposomes","volume":"38","author":"Federizon","year":"2020","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127742_bb0070","article-title":"Copper-based nanoscale coordination polymers augmented tumor radioimmunotherapy for immunogenic cell death induction and T-cell infiltration","volume":"17","author":"Wang","year":"2021","journal-title":"Small Weinh Bergstr Ger"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127742_bb0075","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3390\/vaccines10050819","article-title":"An overview of vaccine adjuvants: current evidence and future perspectives","volume":"10","author":"Facciol\u00e0","year":"2022","journal-title":"Vaccines"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127742_bb0080","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1586\/14760584.8.3.293","article-title":"Vaccine adjuvants: scientific challenges and strategic initiatives","volume":"8","author":"Harandi","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2025.127742_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2013.12.007","article-title":"Immunomodulatory properties of the vaccine adjuvant alum","volume":"28","author":"Oleszycka","year":"2014","journal-title":"Curr Opin Immunol"},{"issue":"Pt 8","key":"10.1016\/j.vaccine.2025.127742_bb0090","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1099\/0022-1317-70-8-2037","article-title":"Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein","volume":"70","author":"Mason","year":"1989","journal-title":"J Gen Virol"},{"issue":"46","key":"10.1016\/j.vaccine.2025.127742_bb0095","doi-asserted-by":"crossref","first-page":"46007","DOI":"10.1074\/jbc.M307776200","article-title":"Structural basis of a flavivirus recognized by its neutralizing antibody: solution structure of the domain III of the Japanese encephalitis virus envelope protein","volume":"278","author":"Wu","year":"2003","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127742_bb0100","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00430-007-0043-4","article-title":"Immunogenicity and protective efficacy of the E. coli-expressed domain III of Japanese encephalitis virus envelope protein in mice","volume":"196","author":"Alka","year":"2007","journal-title":"Med Microbiol Immunol (Berl)"},{"issue":"19","key":"10.1016\/j.vaccine.2025.127742_bb0105","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1016\/S0264-410X(03)00042-2","article-title":"The domain III fragment of Japanese encephalitis virus envelope protein: mouse immunogenicity and liposome adjuvanticity","volume":"21","author":"Wu","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127742_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127143","article-title":"Neutralizing antibodies against the Japanese encephalitis virus are produced by a 12 kDa E. coli- expressed envelope protein domain III (EDIII) tagged with a solubility-controlling peptide","volume":"56","author":"Islam","year":"2025","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127742_bb0115","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.3390\/ijms24032393","article-title":"The immunogenicity of DENV1-4 ED3s strongly differ despite their almost identical three-dimensional structures and high sequence similarities","volume":"24","author":"Islam","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127742_bb0120","doi-asserted-by":"crossref","first-page":"21561","DOI":"10.1038\/s41598-020-78639-x","article-title":"Chimeric flavivirus enables evaluation of antibodies against dengue virus envelope protein in vitro and in vivo","volume":"10","author":"Kurosu","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127742_bb0125","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.bbrc.2017.11.137","article-title":"Construction of a high-yield dengue virus by replacing nonstructural proteins 3-4B without increasing virulence","volume":"495","author":"Phanthanawiboon","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127742_bb0130","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3329\/brc.v8i1.57042","article-title":"All four dengue virus serotypes co-circulate in concurrent dengue infections in a single dengue session in Chittagong, Bangladesh","volume":"8","author":"Roy","year":"2022","journal-title":"Biores Commun"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127742_bb0135","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.vascn.2004.08.014","article-title":"HEK293 cell line: a vehicle for the expression of recombinant proteins","volume":"51","author":"Thomas","year":"2005","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2025.127742_bb0140","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2025.127742_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00333","article-title":"Anti-dengue ED3 long-term immune response with T-cell memory generated using solubility controlling peptide tags","volume":"11","author":"Islam","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2025.127742_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.671590","article-title":"Solubility controlling peptide tags of opposite charges generate a bivalent immune response against dengue ED3 serotypes 3 and 4","volume":"12","author":"Rahman","year":"2021","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127742_bb0155","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s12551-022-01011-y","article-title":"Biophysical studies of amorphous protein aggregation and in vivo immunogenicity","volume":"14","author":"Kuroda","year":"2022","journal-title":"Biophys Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127742_bb0160","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1084\/jem.165.1.64","article-title":"IgG2a restriction of murine antibodies elicited by viral infections","volume":"165","author":"Coutelier","year":"1987","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127742_bb0165","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1038\/s41467-024-47450-x","article-title":"Adjuvant-dependent impact of inactivated SARS-CoV-2 vaccines during heterologous infection by a SARS-related coronavirus","volume":"15","author":"Dillard","year":"2024","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127742_bb0170","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1002\/eji.200939555","article-title":"Pathways of memory CD8+ T-cell development","volume":"39","author":"Bannard","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2025.127742_bb0175","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","article-title":"TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties","volume":"7","author":"Mosmann","year":"1989","journal-title":"Annu Rev Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127742_bb0180","doi-asserted-by":"crossref","first-page":"8281","DOI":"10.1128\/JVI.72.10.8281-8288.1998","article-title":"Long-term CD4 Th1 and Th2 memory following acute lymphocytic choriomeningitis virus infection","volume":"72","author":"Whitmire","year":"1998","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127742_bb0185","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2025.127742_bb0190","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jbiotec.2025.01.006","article-title":"Ni2+\u2212induced selective precipitation of his-tagged recombinant proteins shortens purification time while maintaining high yield","volume":"399","author":"Islam","year":"2025","journal-title":"J Biotechnol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127742_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-018-0089-x","article-title":"Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want","volume":"3","author":"HogenEsch","year":"2018","journal-title":"npj Vaccines"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127742_bb0200","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/jor.20826","article-title":"Soluble and particulate co-Cr-Mo alloy implant metals activate the inflammasome danger signaling pathway in human macrophages: a novel mechanism for implant debris reactivity","volume":"27","author":"Caicedo","year":"2009","journal-title":"J Orthop Res"},{"issue":"23","key":"10.1016\/j.vaccine.2025.127742_bb0205","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1182\/blood-2009-07-230631","article-title":"IL-6 increases B-cell IgG production in a feed-forward proinflammatory mechanism to skew hematopoiesis and elevate myeloid production","volume":"115","author":"Maeda","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127742_bb0210","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cellimm.2013.04.003","article-title":"Toll-like receptor 4 signaling pathway mediates proinflammatory immune response to cobalt-alloy particles","volume":"282","author":"Potnis","year":"2013","journal-title":"Cell Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127742_bb0215","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/cvr\/cvv154","article-title":"Selectins: initiators of leucocyte adhesion and signalling at the vascular wall","volume":"107","author":"McEver","year":"2015","journal-title":"Cardiovasc Res"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127742_bb0220","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1128\/JVI.77.4.2600-2606.2003","article-title":"A functional epitope determinant on domain III of the Japanese encephalitis virus envelope protein interacted with neutralizing-antibody combining sites","volume":"77","author":"Lin","year":"2003","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127742_bb0225","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1128\/JVI.06072-11","article-title":"Crystal structure of the Japanese encephalitis virus envelope protein","volume":"86","author":"Luca","year":"2012","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25010394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25010394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:49:52Z","timestamp":1769024992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25010394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":45,"alternative-id":["S0264410X25010394"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127742","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trace amounts of cobalt serve as an adjuvant for unglycosylated JEV-ED3 expressed in E. coli, inducing a potent virus-neutralizing immune response","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127742","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"127742"}}